The American Cancer Society is calling on the Trump administration to restore access to comprehensive scientific data.
BirGün accessed the report on the use of ‘surfactant group’ drugs used in the infant treatment and subject of the ‘newborn ...
There is an unmet need for therapies targeting Duchenne muscular dystrophy (DMD)–related heart disease, and phase 2 results ...
The Vivacity-MG3 study is currently in its open-label extension phase, which is investigating the longer-term safety and ...
Keymed Biosciences Announces Approval of Stapokibart For the Treatment of Seasonal Allergic Rhinitis
KeyMed Biosciences (HKEX: 02162) today announced the National Medical Products Administration (the 'NMPA') of China has recently approved the supplemental New Drug Application (the 'sNDA') of ...
A novel drug regimen tested for the first time by researchers at Fred Hutch Cancer Center has shown great promise in ...
Discover the latest developments in potential ALS treatments with COYA-302 and COYA-303, set to impact the $1.33 billion ...
Unlike opium, nitazenes and other synthetic opioids can be produced anywhere in the world using precursor chemicals that are often uncontrolled.
Here, we explain the facts behind several more of Robert F. Kennedy Jr.’s claims during his two Senate hearings as nominee ...
The United Nations Office on Drugs and Crime (UNODC) strives to meaningfully engage youth in substance use prevention efforts through global platforms, where young people can reflect on the impact of ...
19h
Hosted on MSNBreakthrough sickle cell drug causes excitementA groundbreaking sickle cell disease treatment has been approved for use in the UK's National Health Service (NHS). The treatment offers patients with severe forms of the condition hope for a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results